about
Predicting the occurrence of embolic events: an analysis of 1456 episodes of infective endocarditis from the Italian Study on Endocarditis (SEI).Streptococcus salivarius meningitis and sphenoid sinus mucocele. Case report and literature review.Sildenafil and bosentan plasma concentrations in a human immunodeficiency virus- infected patient with pulmonary arterial hypertension treated with ritonavir-boosted protease inhibitorBosentan and sildenafil in the treatment of HIV-associated pulmonary hypertension.HIV infection and pulmonary arterial hypertension.Extra-cerebral severe infections associated with haemorrhagic hereditary telangiectasia (Rendu-Osler-Weber Disease): five cases and a review of the literature.Pharmacological treatment of HIV-associated pulmonary hypertension.Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M).Persistent detection of dengue virus RNA in vaginal secretion of a woman returning from Sri Lanka to Italy, April 2017.Current features of infective endocarditis in persons on hemodialysis: a prevalence study with case control design from the prospective multicenter SEI cohort.Saccharomyces cerevisiae fungemia in a neutropenic patient treated with Saccharomyces boulardii.Multiple bilateral pulmonary "fungus balls" in an immunocompetent patient unsuitable for surgical treatment: efficacy of azoles treatment.Central venous catheter flushing and an outbreak of bacteremia among pediatric hematology-oncology patients.Disinfection of personal protective equipment for management of Ebola patients.Criteria for discharge of patients with Ebola virus diseases in high-income countries.QTc prolongation in human immunodeficiency virus-infected persons.QTc interval prolongation during favipiravir therapy in an Ebolavirus-infected patient.Epidemiology, characteristics, and outcome of infective endocarditis in Italy: the Italian Study on Endocarditis.Pulmonary Arterial Hypertension in HIV-infected PatientsAtypical disseminated leishmaniasis resembling post-kala-azar dermal leishmaniasis in an HIV-infected patientIn vitro Activity Effects of Twelve Antibiotics Alone and in Association against Twenty-Seven Enterococcus faecalis Strains Isolated from Italian Patients with Infective Endocarditis: High in vitro Synergistic Effect of the Association Ceftriaxone-FoGranulocyte transfusions from G-CSF-stimulated donors for the treatment of severe infections in neutropenic pediatric patients with onco-hematological diseasesSildenafil Plasma Concentrations in Two HIV Patients with Pulmonary Hypertension Treated with Ritonavir-Boosted Protease InhibitorsPulmonary hypertension in individuals with HIV infectionRole of antiretroviral treatment in prolonging QTc interval in HIV-positive patientsQT interval prolongation and antiretroviral treatment: another point of interestEarly syphilitic hepatitis in an immunocompetent patient: really so uncommon?Rhino-orbital zygomycosis secondary to diabetic ketoacidosis in an HIV-positive patient: case report and literature reviewPulmonary arterial hypertension and HIV infectionProfile of infective endocarditis in a referral hospital over the last 24 years
P50
Q33914152-319186A0-44AA-44B3-8A96-1BFCA33804D9Q34558224-B26F2CD3-BBD6-4D0E-98A3-C410E3897EFBQ35290066-889C486A-C597-4E88-9E2C-66EAED550CA3Q37481861-174C835C-6FCF-4964-803B-1C775212B9C0Q37867676-93098C1E-51E0-4C25-9F1F-B3AEA2FBB56FQ38197837-70C5811F-B234-408F-B97E-7FB027C59E2AQ38728500-23581606-CCF7-4885-B855-D62C4CA2D936Q38972140-0A83941C-1FAD-484D-A492-3CE49959938DQ40037926-16694868-186C-402E-AC27-69E6F1007EBCQ40093594-E0B40227-6E09-453E-891C-5AECD2E8AF41Q40611581-A7361EA5-97DF-4E29-BC3B-CD672910478BQ42269536-555330FE-0583-4E7C-8ECC-9505AAA2C8E8Q43607585-F1DB2B37-046D-4F96-980D-1DB382481461Q44100380-62BFA056-C79F-4839-8440-6E4923FF0050Q44100989-821A192E-AF06-42DF-B238-28052F3E9450Q45410149-D35DBA7E-41E4-4908-99C6-07CDD85D81CEQ47559990-7EECF9F6-5ACB-44EB-A008-8C2E0CA40EA4Q47605089-ADB08BBF-27E6-4B06-8C56-1DB4AFB2BEC2Q59283911-3A34C447-0543-41C0-9D23-FFE46078C7E4Q59304356-0E091C1E-7C22-4DD3-8B53-45DAFBEDE9E0Q59400712-70DDBBC8-2746-4728-96AA-7DEAD48B47D4Q60211030-A7021986-519E-4575-86C9-E7A283B80EBFQ60586181-07DCE7F4-2259-4955-A1E8-FC2F0957FC24Q79279232-59156644-F994-4D74-A11C-C12E48D70DDDQ79438032-773E7CFD-33AE-4673-B197-EB37B285EC99Q80179492-417468E4-ABB2-4E1F-AAF6-74DE651B879FQ80703346-01997A0E-6567-41C4-97EF-9F7D875D96C1Q81572772-0A546EF9-456C-40FD-B08D-8103CE776766Q82194939-6A5DA279-1FE4-432D-8DC3-00A354818E51Q82405259-2AD658CE-B18E-4DA2-A04A-C131D85B0B7A
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Pierangelo Chinello
@ast
Pierangelo Chinello
@en
Pierangelo Chinello
@es
Pierangelo Chinello
@nl
Pierangelo Chinello
@sl
type
label
Pierangelo Chinello
@ast
Pierangelo Chinello
@en
Pierangelo Chinello
@es
Pierangelo Chinello
@nl
Pierangelo Chinello
@sl
prefLabel
Pierangelo Chinello
@ast
Pierangelo Chinello
@en
Pierangelo Chinello
@es
Pierangelo Chinello
@nl
Pierangelo Chinello
@sl
P106
P1153
16303182700
P31
P496
0000-0002-7341-9000